Ignite Creation Date:
2024-05-06 @ 2:34 PM
Last Modification Date:
2024-10-26 @ 1:33 PM
Study NCT ID:
NCT04351334
Status:
COMPLETED
Last Update Posted:
2023-03-27
First Post:
2020-04-15
Brief Title:
Anaplastic Lymphoma Kinase ALK-Positive Non-small Cell Lung Cancer NSCLC Post-alectinib Treatment Patterns
Sponsor:
Organization:
Pfizer